← Back to all trials
Recruiting
NCT05753449
Burst-Type Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease
Conditions: Parkinson Disease, Deep Brain Stimulation
Sex: All
Ages: 18 Years – 85 Years
Phase: NA
Enrollment: 5
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Location: United States
Summary
This is a study to evaluate Deep brain stimulation (DBS) burst-type electrical stimulation programming verses standard DBS programming.
Burst-type DBS is defined as a novel stimulation protocol in which intermittent bursts of traditional high-frequency rectangular wave stimulation are delivered.
Burst type DBS may improve the efficacy and durability of DBS pulse generator.
Eligibility Criteria
Inclusion Criteria:Bilateral DBS-STN (subthalamic nucleus) target for idiopathic Parkinson's disease implanted minimum 6 months prior to the day of study enrollmentStable DBS programming settings and Parkinson's disease medications defined as no changes to either within past 6 monthsComfortable using DBS controller to turn off device prior to study visitsAble to provide informed consent and complete follow-up visitsExclusion Criteria:DBS technology other than Boston scientific Genus/GeviaUnable to complete follow-up visitsDBS brain targets other than STN (subthalamic nucleus)Signs of progressive cognitive decline
Source: ClinicalTrials.gov (NCT05753449). StuddyBuddy aggregates publicly available trial information.
